ACSL5
Basic information
Region (hg38): 10:112374116-112428379
Previous symbols: [ "FACL5" ]
Links
Phenotypes
GenCC
Source:
- diarrhea 13 (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACSL5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 30 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 30 | 3 | 4 |
Variants in ACSL5
This is a list of pathogenic ClinVar variants found in the ACSL5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-112376317-C-T | not specified | Likely benign (Sep 14, 2022) | ||
10-112376319-C-G | not specified | Uncertain significance (Mar 29, 2023) | ||
10-112376345-C-A | not specified | Uncertain significance (Dec 13, 2023) | ||
10-112376369-G-C | not specified | Uncertain significance (Jun 27, 2022) | ||
10-112376374-C-T | not specified | Likely benign (Aug 08, 2022) | ||
10-112394984-C-T | not specified | Uncertain significance (Nov 03, 2023) | ||
10-112395065-C-A | Benign (May 09, 2018) | |||
10-112395079-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
10-112398947-G-C | not specified | Uncertain significance (Mar 14, 2023) | ||
10-112404540-C-A | not specified | Uncertain significance (May 18, 2023) | ||
10-112404741-T-G | not specified | Uncertain significance (Sep 06, 2022) | ||
10-112408412-C-T | Benign (Jun 12, 2018) | |||
10-112408450-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
10-112408455-T-A | not specified | Uncertain significance (Dec 02, 2021) | ||
10-112408495-A-C | not specified | Uncertain significance (Dec 14, 2023) | ||
10-112409515-G-A | not specified | Uncertain significance (May 11, 2022) | ||
10-112409525-T-C | not specified | Uncertain significance (Aug 17, 2021) | ||
10-112409597-T-A | not specified | Uncertain significance (Oct 14, 2023) | ||
10-112409682-T-A | Likely benign (Feb 01, 2024) | |||
10-112410592-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
10-112411915-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
10-112411920-C-G | not specified | Uncertain significance (Dec 27, 2022) | ||
10-112413242-A-T | not specified | Uncertain significance (May 07, 2024) | ||
10-112416919-A-G | not specified | Uncertain significance (Jun 16, 2024) | ||
10-112416935-G-A | Benign (May 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACSL5 | protein_coding | protein_coding | ENST00000356116 | 21 | 54363 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.89e-9 | 0.999 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.717 | 369 | 410 | 0.900 | 0.0000212 | 4841 |
Missense in Polyphen | 129 | 161.08 | 0.80082 | 1941 | ||
Synonymous | 0.960 | 144 | 159 | 0.903 | 0.00000903 | 1411 |
Loss of Function | 2.96 | 21 | 41.6 | 0.505 | 0.00000191 | 517 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000511 | 0.000511 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000167 | 0.000167 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acyl-CoA synthetases (ACSL) activate long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL5 may activate fatty acids from exogenous sources for the synthesis of triacylglycerol destined for intracellular storage (By similarity). Utilizes a wide range of saturated fatty acids with a preference for C16-C18 unsaturated fatty acids (By similarity). It was suggested that it may also stimulate fatty acid oxidation (By similarity). At the villus tip of the crypt-villus axis of the small intestine may sensitize epithelial cells to apoptosis specifically triggered by the death ligand TRAIL. May have a role in the survival of glioma cells. {ECO:0000250, ECO:0000269|PubMed:17681178, ECO:0000269|PubMed:18806831, ECO:0000269|PubMed:19459852}.;
- Pathway
- Adipocytokine signaling pathway - Homo sapiens (human);Peroxisome - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Fatty acid degradation - Homo sapiens (human);Fatty acid biosynthesis - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Ferroptosis - Homo sapiens (human);Fatty Acid Beta Oxidation;Fatty Acid Biosynthesis;PPAR signaling pathway;Liver steatosis AOP;stearate biosynthesis;Metabolism of lipids;Fatty acyl-CoA biosynthesis;fatty acid activation;Leukotriene metabolism;Omega-3 fatty acid metabolism;Metabolism;Fatty acid metabolism;γ-linolenate biosynthesis;Mono-unsaturated fatty acid beta-oxidation;Omega-6 fatty acid metabolism;Di-unsaturated fatty acid beta-oxidation;Phytanic acid peroxisomal oxidation;fatty acid β-oxidation (peroxisome);icosapentaenoate biosynthesis II (metazoa);fatty acid β-oxidation;Synthesis of very long-chain fatty acyl-CoAs
(Consensus)
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.837
- rvis_EVS
- 0.27
- rvis_percentile_EVS
- 70.64
Haploinsufficiency Scores
- pHI
- 0.146
- hipred
- N
- hipred_score
- 0.499
- ghis
- 0.426
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.791
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acsl5
- Phenotype
- skeleton phenotype; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- long-chain fatty acid metabolic process;long-chain fatty-acyl-CoA biosynthetic process
- Cellular component
- nucleus;nucleolus;mitochondrion;mitochondrial outer membrane;endoplasmic reticulum membrane;membrane;integral component of membrane
- Molecular function
- long-chain fatty acid-CoA ligase activity;ATP binding;decanoate-CoA ligase activity